体积 2, 问题 5 (2012)
特刊文章
Bioequivalence of a pioglitazone-glimepiride combination tablet versus coadministered single-dose pioglitazone and glimepiride in healthy Japanese subjects
Shinzo Hiroi, Kumi Matsuno, Masashi Hirayama, Kenji Kuriyama & Koji Kawakami
特刊文章
Evaluation of the bioequivalence of a fixed-dose combination tablet of pioglitazone-metformin versus commercial tablets in healthy Japanese male volunteers
Shinzo Hiroi, Kumi Matsuno, Masashi Hirayama, Takaki Hayakawa,Norihito Yoshioka & Koji Kawakami
特刊文章
Bioequivalence evaluation of pioglitazone orally disintegrating tablet formulation
Shinzo Hiroi, Kumi Matsuno, Masashi Hirayama, Takaki Hayakawa,Norihito Yoshioka & Koji Kawakami
研究文章
Transition in Type 1 diabetes mellitus from a tertiary pediatric center: what are we doing before they walk out the door?
Mary White, Michele A O\'Connell & Fergus J Cameron
研究文章
Factors associated with participation in a diabetes prevention program in Austria: a prospective cohort study
Yvonne Teuschl, Karl Matz, Alexandra Dachenhausen,Jaakko Tuomilehto & Michael Brainin
评论文章
Biomarkers for evaluating renal function decline in diabetes: where are we now?
Janet K Snell-Bergeon
评论文章
Molecular action and pharmacogenetics of metformin: current understanding of an old drug
Graham Rena, Ewan R Pearson& Kei Sakamoto
评论文章
In search of improved glucose control: helping the patient decide between insulin injections and infusion pump therapy
Erin D Roe, Jason S Woo & Philip Raskin
评论文章
Doctor, stop needling me: an update on alternative routes of insulin administration
Erin D Roe, Jason S Woo & Philip Raskin
评论文章
Components and validity of risk scores for screening for Type 2 diabetes mellitus
Chung T Nguyen, Andy H Lee & Colin W Binns
